220 related articles for article (PubMed ID: 28223027)
1. Mapping of the continuous epitopes displayed on the Clostridium perfringens type D epsilon-toxin.
Alves GG; Machado-de-Ávila RA; Chávez-Olórtegui CD; Silva ROS; Lobato FCF
Braz J Microbiol; 2017; 48(3):570-575. PubMed ID: 28223027
[TBL] [Abstract][Full Text] [Related]
2. Naturally acquired antibodies against Clostridium perfringens epsilon toxin in goats.
Veschi JL; Bruzzone OA; Losada-Eaton DM; Dutra IS; Fernandez-Miyakawa ME
Vet Immunol Immunopathol; 2008 Sep; 125(1-2):198-202. PubMed ID: 18538416
[TBL] [Abstract][Full Text] [Related]
3. Evaluation of different fluids for detection of Clostridium perfringens type D epsilon toxin in sheep with experimental enterotoxemia.
Layana JE; Fernandez Miyakawa ME; Uzal FA
Anaerobe; 2006 Aug; 12(4):204-6. PubMed ID: 16857397
[TBL] [Abstract][Full Text] [Related]
4. Functional analysis of neutralizing antibodies against Clostridium perfringens epsilon-toxin.
McClain MS; Cover TL
Infect Immun; 2007 Apr; 75(4):1785-93. PubMed ID: 17261609
[TBL] [Abstract][Full Text] [Related]
5. Detection of beta2 and major toxin genes by PCR in Clostridium perfringens field isolates of domestic animals suffering from enteritis or enterotoxaemia.
Sting R
Berl Munch Tierarztl Wochenschr; 2009; 122(9-10):341-7. PubMed ID: 19863004
[TBL] [Abstract][Full Text] [Related]
6. Clostridium perfringens toxin types in hooded seals in the Greenland Sea, determined by PCR and ELISA.
Aschfalk A; Müller W
J Vet Med B Infect Dis Vet Public Health; 2001 Dec; 48(10):765-9. PubMed ID: 11846022
[TBL] [Abstract][Full Text] [Related]
7. Enterotoxemia associated with beta2 toxin-producing Clostridium perfringens type A in two Asiatic black bears (Selenarctos thibetanus).
Greco G; Madio A; Martella V; Campolo M; Corrente M; Buonavoglia D; Buonavoglia C
J Vet Diagn Invest; 2005 Mar; 17(2):186-9. PubMed ID: 15825503
[TBL] [Abstract][Full Text] [Related]
8. Selection of a Clostridium perfringens type D epsilon toxin producer via dot-blot test.
Gonçalves LA; Lobato ZI; Silva RO; Salvarani FM; Pires PS; Assis RA; Lobato FC
Arch Microbiol; 2009 Nov; 191(11):847-51. PubMed ID: 19779698
[TBL] [Abstract][Full Text] [Related]
9. Oral immunization of mice against Clostridium perfringens epsilon toxin with a Lactobacillus casei vector vaccine expressing epsilon toxoid.
Alimolaei M; Golchin M; Daneshvar H
Infect Genet Evol; 2016 Jun; 40():282-287. PubMed ID: 27012151
[TBL] [Abstract][Full Text] [Related]
10. [Characterization of a Cl. Perfringens type D strain, isolated in the field and optimization of epsilon toxin biosynthesis in a cell culture].
Maaroufi A; Metoui W; Rahmouni S; Ghram A
Arch Inst Pasteur Tunis; 2000; 77(1-4):67-72. PubMed ID: 14658231
[TBL] [Abstract][Full Text] [Related]
11. Clostridium perfringens epsilon toxin: the third most potent bacterial toxin known.
Alves GG; Machado de Ávila RA; Chávez-Olórtegui CD; Lobato FC
Anaerobe; 2014 Dec; 30():102-7. PubMed ID: 25234332
[TBL] [Abstract][Full Text] [Related]
12. Quality assurance of C. perfringens epsilon toxoid vaccines--ELISA versus mouse neutralisation test.
Rosskopf-Streicher U; Volkers P; Noeske K; Werner E
ALTEX; 2004; 21 Suppl 3():65-9. PubMed ID: 15057410
[TBL] [Abstract][Full Text] [Related]
13. Immunogenicity of a Trivalent Recombinant Vaccine Against Clostridium perfringens Alpha, Beta, and Epsilon Toxins in Farm Ruminants.
Moreira GM; Salvarani FM; da Cunha CE; Mendonça M; Moreira ÂN; Gonçalves LA; Pires PS; Lobato FC; Conceição FR
Sci Rep; 2016 Mar; 6():22816. PubMed ID: 27004612
[TBL] [Abstract][Full Text] [Related]
14. New insights into Clostridium perfringens epsilon toxin activation and action on the brain during enterotoxemia.
Freedman JC; McClane BA; Uzal FA
Anaerobe; 2016 Oct; 41():27-31. PubMed ID: 27321761
[TBL] [Abstract][Full Text] [Related]
15. Clostridium perfringens toxin types from wild-caught Atlantic cod (Gadus morhua L.), determined by PCR and ELISA.
Aschfalk A; Müller W
Can J Microbiol; 2002 Apr; 48(4):365-8. PubMed ID: 12030710
[TBL] [Abstract][Full Text] [Related]
16. Detection of alpha- and epsilon-toxigenic Clostridium perfringens type D in sheep and goats using a DNA amplification technique (PCR).
Miserez R; Frey J; Buogo C; Capaul S; Tontis A; Burnens A; Nicolet J
Lett Appl Microbiol; 1998 May; 26(5):382-6. PubMed ID: 9674169
[TBL] [Abstract][Full Text] [Related]
17. A low-toxic site-directed mutant of Clostridium perfringens ε-toxin as a potential candidate vaccine against enterotoxemia.
Li Q; Xin W; Gao S; Kang L; Wang J
Hum Vaccin Immunother; 2013 Nov; 9(11):2386-92. PubMed ID: 23835363
[TBL] [Abstract][Full Text] [Related]
18. Antibody response to the epsilon toxin of Clostridium perfringens following vaccination of Lama glama crias.
Bentancor AB; Halperin P; Flores M; Iribarren F
J Infect Dev Ctries; 2009 Sep; 3(8):624-7. PubMed ID: 19801806
[TBL] [Abstract][Full Text] [Related]
19. Development and application of an oral challenge mouse model for studying Clostridium perfringens type D infection.
Fernandez-Miyakawa ME; Sayeed S; Fisher DJ; Poon R; Adams V; Rood JI; McClane BA; Saputo J; Uzal FA
Infect Immun; 2007 Sep; 75(9):4282-8. PubMed ID: 17562765
[TBL] [Abstract][Full Text] [Related]
20. Potency against enterotoxemia of a recombinant Clostridium perfringens type D epsilon toxoid in ruminants.
Lobato FC; Lima CG; Assis RA; Pires PS; Silva RO; Salvarani FM; Carmo AO; Contigli C; Kalapothakis E
Vaccine; 2010 Aug; 28(38):6125-7. PubMed ID: 20670910
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
